Encode-Guess-Educated

 view release on metacpan or  search on metacpan

t/data/cp1252/10329150.cp1252  view on Meta::CPAN

   Crystal structure of cyanovirin-N, a potent HIV-inactivating protein,
   shows unexpected domain swapping [73]^1

   Fan Yang [74]^1, Carole A. Bewley [75]^2, John M. Louis [76]^2, Kirk R.
   Gustafson [77]^3, Michael R. Boyd [78]^3, Angela M. Gronenborn [79]^2,
   G. Marius Clore [80]^2 and Alexander Wlodawer [81]^1^,
   [82]^Corresponding Author Contact Information ^, [83]^E-mail The
   Corresponding Author

   ^1 Macromolecular Structure Laboratory, ABL-Basic Research Program,
   NCI-Frederick Cancer Research and Development Center, Frederick, MD
   21702-1201, USA

   ^2 Laboratory of Chemical Physics, National Institute of Diabetes and
   Digestive and Kidney Diseases, National Institutes of Health, Bethesda
   MD 20892-0520, USA

   ^3 Laboratory of Drug Discovery Research and Development DTP,
   NCI-Frederick Cancer Research and Development Center, Frederick, MD
   21702-1201, USA

t/data/cp1252/10677497.cp1252  view on Meta::CPAN

   21. [215]↵
         1. Isaacson R A ,
         2. Lendzian F ,
         3. Abresch E C ,
         4. Lubitz W ,
         5. Feher G
       (1995) Biophys J 69:311–322, pmid:8527644.
       [216]Abstract/FREE Full Text
   22. [217]↵
         1. McPherson A
       (1999) Crystallization of Biological Macromolecules (Cold Spring
       Harbor Lab. Press, Plainview, NY).
   23. [218]↵
         1. Allen J P
       (1994) Proteins Struct Funct Genet 20:283–286, pmid:7892177.
       [219]CrossRef[220]Medline
   24. [221]↵
         1. Rodgers D W
       (1997) Methods Enzymol 276:183–203.
   25. [222]↵
         1. Leslie A G W

t/data/demos/14751857.cp1252  view on Meta::CPAN

          View larger version (20K):  [in this window]  [in a new window]  Fig. 7. N -acetyl-l-cysteine (NAC) in vivo alleviates RBC deformability decrease in septic G-6-PDH-deficient animals. Sham-operated or septic animals were treated by subcutane...

             DISCUSSION       TOP   ABSTRACT   MATERIALS AND METHODS   RESULTS   DISCUSSION   GRANTS   REFERENCES    This study demonstrates for the first time that G-6-PDH deficiency exacerbates the magnitude of decreased RBC deformability after pol...

  It is well known that the life span of circulating erythrocytes is 60 days (half of normal) in the class III human deficiencies, even in otherwise healthy individuals ( 34 ). In mice, the life span of circulating erythrocytes is 40 days, and it is ...

  The more pronounced decrease in erythrocyte deformability in septic deficient vs. WT animals was readily detectible in whole blood ( Fig. 3 ) as well as after comparing erythrocyte subpopulations ( Fig. 4 H ). However, the differences in decreased ...

  Elevated membrane abundance of band 3 tetramers is accompanied by increased associations between band 3 and the cytoskeleton. Elevated band 3 association with the cytoskeleton has been shown to parallel the decrease in RBC deformability ( 21, 39 ) ...

  The role of oxidative stress in causing decreased RBC deformability during the physiological aging process of erythrocytes is well documented ( 5, 13 ). In fact, during the normal process of oxygen exchange, erythrocytes are exposed to oxidative st...

  The notion that oxidative stress is greater in G-6-PDH-deficient animals is further supported by our findings that NAC alleviated the decrease in erythrocyte deformability in septic deficient animals. However, this observation must be interpreted w...

  It is evident from our findings that polymicrobial sepsis resulted in a similar decrease in the number of circulating neutrophils, lymphocytes, and platelets in deficient and WT animals at 24 h after CLP, although the G-6-PDH-deficient animals deve...

  Infection-induced anemia in critically ill patients is a common occurrence with important clinical implications ( 37, 45, 48, 50 ). In previous studies using the CLP septic model, anemia was observed in BALB/c mice ( 20 ) and young (4–5 wk old) C57...

  Previous investigations on severely injured G-6-PDH-deficient trauma patients indicated that these patients had an increased incidence of sepsis, a longer duration of the systemic inflammatory response syndrome, augmented monocyte activation, blunt...

  The role of G-6-PDH deficiency in the protection against malaria is well accepted; however, the mechanism of protection remains only partially elucidated ( 10, 12, 42 ). Our current observations may have potential implications in this context as we...

t/data/good/10398587.utf8  view on Meta::CPAN

   [141]Bhargava and Leonard 1995. H.N. Bhargava and P.A. Leonard,
   Triclosan: applications and safety. Am. J. Infect. Control 24 (1995),
   pp. 209–218.

   [142]Brunger 1992. A.T. Brünger. X-PLOR version 3.1 - A System for
   X-ray Crystallography and NMR, Yale University Press, New Haven, CT
   (1992).

   [143]Christopher 1998. J.A. Christopher. SPOCK: The Structural
   Properties Observation and Calculation Kit (Program Manual) The Center
   for Macromolecular Design, Texas A&M University, Texas, USA, College
   Station (1998).

   [144]Heath et al 1998. R.J. Heath, Y.-T. Yu, M.A. Shapiro, E. Olson and
   C.O. Rock, Broad spectrum antimicrobial biocides target the FabI
   component of fatty acid synthesis. J. Biol. Chem. 273 (1998), pp.
   30316–30320. [145]Full Text via CrossRef | [146]View Record in Scopus |
   [147]Cited By in Scopus (175)

   [148]Kraulis 1991. P.J. Kraulis, MOLSCRIPT - a program to produce both
   detailed and schematic plots of protein structures. J. Appl.

t/data/good/10737790.utf8  view on Meta::CPAN

       [184]Web of Science
   21. [185]↵
         1. Blessing R H
       (1997) J Appl Crystallogr 30:421–426.
       [186]CrossRef
   22. [187]↵
         1. Blessing R H ,
         2. Guo D Y ,
         3. Langs D A
         1. Fortier S
       (1998) in Direct Methods for Solving Macromolecular Structures,
       NATO ASI Series Volume, Series C: Mathematical and Physical
       Sciences, ed Fortier S (Kluwer, Dordrecht, The Netherlands), 507,
       pp 47–71.
   23. [188]↵
         1. Brünger A T
       (1992) Nature (London) 355:472–474.
       [189]CrossRef
   24. [190]↵
         1. Hansen N K ,
         2. Coppens P

t/data/good/11118459.utf8  view on Meta::CPAN

         1. Laskowski R.,
         2. MacArthur M.,
         3. Moss D.,
         4. Thornton J.
       (1993) J. Appl. Crystallogr. 26:91–97.
   19. [146]↵
         1. Barton G. J.
       (1993) Protein Eng. 6:37–40.
   20. [147]↵
         1. Christopher J. A.
       (1998) SPOCK . (The Center for Macromolecular Design, Texas A&M
       University, College Station, TX).
   21. [148]↵
         1. Merritt E. A.,
         2. Murphy M. E. P.
       (1994) Acta Crystallogr. Sect. D Biol. Crystallogr. 50:869–873.
   22. [149]↵
         1. Sheu K. F.,
         2. Frey P. A.
       (1978) J. Biol. Chem. 253:3378–3780.
   23. [150]↵

t/data/good/11278591.utf8  view on Meta::CPAN

        14. Warren G. L.
       (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54:905–921.
   25. [181]↵
         1. Laskowski R.,
         2. MacArthur M.,
         3. Moss D.,
         4. Thornton J.
       (1993) J. Appl. Crystallogr. 26:91–97.
   26. [182]↵
         1. Christopher J. A.
       (1998) SPOCK (The Center for Macromolecular Design, Texas A&M
       University, College Station, TX).
   27. [183]↵
         1. Merritt E. A.,
         2. Murphy M. E. P.
       (1994) Acta Crystallogr. Sect. D Biol. Crystallogr. 50:869–873.
   28. [184]↵
         1. Barton G. J.
       (1993) Protein Eng. 6:37–40.
   29. [185]↵
         1. Schlunegger M. P.,

t/data/good/11493601.utf8  view on Meta::CPAN

    1. [16]Gurvan Michel[17]‡[18]§,
    2. [19]Laurent Chantalat[20]‡,
    3. [21]Eric Fanchon[22]‡,
    4. [23]Bernard Henrissat[24]¶,
    5. [25]Bernard Kloareg[26]§ and
    6. [27]Otto Dideberg[28]‡[29]‖

    1.


    From the ^‡Laboratoire de Cristallographie Macromoléculaire, Institut
    de Biologie Structurale Jean-Pierre Ebel, CNRS/Commissariat Ã…
    l'Energie Atomique, 41, rue Jules Horowitz, 38027 Grenoble Cedex 1,
    France, the ^§Station Biologique de Roscoff, UMR 1931 (CNRS and
    Laboratoires Goëmar), Place Georges Teissier, BP 74, 29682 Roscoff
    Cedex, France, and the ^¶Architecture et Fonction des Macromolécules
    Biologiques, UMR 6098 (CNRS, Universités d'Aix-Marseille I et II), 31
    Chemin Joseph Aiguier, 13402 Marseille Cedex 20, France


   [30]Next Section

 §2§ Abstract §2§

   Carrageenans are gel-forming hydrocolloids extracted from the cell
   walls of marine red algae. They consist ofd-galactose residues bound by

t/data/good/11493601.utf8  view on Meta::CPAN

    4. [163]↵
         1. Morris E. R.,
         2. Rees D. A.,
         3. Robinson G.
       (1980) J. Mol. Biol. 138:349–362.
       [164]CrossRef[165]Medline[166]Web of Science
    5. [167]↵
         1. Viebke C.,
         2. Piculell L.,
         3. Nilsson S.
       (1994) Macromolecules 27:4160–4166.
       [168]CrossRef
    6. [169]↵
         1. Nishinari K.,
         2. Doi E.
         1. Piculell L.,
         2. Svante N.,
         3. Viebke C.,
         4. Zhang W.
       (1994) in Food Hydrocolloids: Structures, Properties and Functions,
       eds Nishinari K., Doi E. (Plenum Press, New York), pp 35–44.

t/data/macroman/11042188.macroman  view on Meta::CPAN

    From the ^tOaSchool of Biosciences, Cardiff University, P. O. Box
    911, Cardiff CF10 3US, Wales, United Kingdom, the^tOcDepartment of
    Medicine, University of Wales College of Medicine, Cardiff CF14 4XN,
    Wales, United Kingdom, ^tOdF. Hoffmann La Roche AG, CH-4070 Basel,
    Switzerland, the ^tOeDepartment of Biochemistry & Molecular Biology,
    University of Florida College of Medicine, Gainesville, Florida
    32610, the ^tOfDepartment of Yeast Genetics, Carlsberg Laboratory,
    DK-2500, Copenhagen Valby, Denmark, the^tOgProtein Structure Section,
    Macromolecular Crystallography Laboratory, National Cancer Institute,
    Frederick, Maryland 21702, the^tOhIntramural Research Support
    Program, SAIC Frederick, National Cancer Institute, Frederick,
    Maryland 21702, and the ^iProgram Core, DBS, National Cancer
    Institute, Frederick, Maryland 21702


   [41]Next Section

 ¤2¤ Abstract ¤2¤